Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05757414 · ClinicalTrials.gov registry record · NA

Lighting Intervention to Improve Sleep

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
57
Enrollment target

NCT05757414 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 57 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05757414, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

50 participants with Parkinson's disease will be recruited to complete actigraphy studies to assess sleep disturbances. For this, participants will wear an Actigraph for seven days. Thirty of these participants with sleep disturbance, will go on to receive a tailored lighting intervention (TLI) to assess the effect on sleep, fatigue, and circadian entrainment via urinary melatonin levels.

Interventions

  • DEVICE Actigraph
  • DEVICE Tailored Lighting Intervention (LIT)

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2021-11-16
Est. Completion 2025-06-30
Phase NA

What the Registry Record Tells You About NCT05757414

The ClinicalTrials.gov registry entry for NCT05757414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Actigraph is the first listed.

NCT05757414 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05757414 about?

NCT05757414 is a clinical study titled "Lighting Intervention to Improve Sleep". 50 participants with Parkinson's disease will be recruited to complete actigraphy studies to assess sleep disturbances. For this, participants will wear an Actigraph for seven days. Thirty of these participants with sleep disturbance, will go on to receive a tailored lighting intervention (TLI) to a...

What is the current status of trial NCT05757414?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2021-11-16. Estimated completion is 2025-06-30.

What interventions are being tested in trial NCT05757414?

The interventions under investigation include: Actigraph (DEVICE), Tailored Lighting Intervention (LIT) (DEVICE).

Who is sponsoring clinical trial NCT05757414?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.